-
Medical Innovation
Mayo Clinic strengthens innovation ecosystem to advance discoveries from ideas to patient impact

Mayo Clinic’s Berg Innovation Exchange and Business Development unite expertise in collaboration, commercialization and venture creation to accelerate innovation worldwide
ROCHESTER, Minn. — Mayo Clinic is strengthening its commitment to advancing healthcare innovation by aligning the Mayo Clinic Berg Innovation Exchange with Mayo Clinic Business Development, creating new opportunities to help promising discoveries reach patients and communities worldwide.
Since its launch, the Berg Innovation Exchange has connected innovators with expertise, mentorship and a global network of collaborators. The exchange has served as a catalyst for innovation within Mayo Clinic and across the broader healthcare ecosystem, bringing together clinicians, researchers, entrepreneurs, industry leaders and investors to explore new approaches to healthcare challenges.
The alignment with Business Development creates stronger connections between early-stage innovation activities and the expertise needed to advance technologies, launch new ventures and expand the reach of Mayo Clinic discoveries.
"From the beginning, the vision of the exchange has been to help innovators find the expertise and opportunities needed to move ideas forward," says Jennie Kung, vice chair of Mayo Clinic Berg Innovation Exchange. "What started as a vision for accelerating innovation has grown into a community of innovators and problem-solvers and positions us to support even more meaningful work in the years ahead."
The exchange helps innovators refine and validate new concepts by providing access to collaborators’ collective expertise. Business Development complements those efforts through capabilities in intellectual property, licensing, venture creation, investment activities and commercialization.
Together, these capabilities create a more seamless pathway from discovery to real-world application, helping promising innovations advance toward broader adoption and patient impact.
"Innovation depends on strong connections between discovery, commercialization and collaboration," says Andy Danielsen, chief business development officer at Mayo Clinic. "This alignment expands opportunities to work with organizations around the world and provides the resources needed to translate ideas into products and services that benefit patients."
As healthcare continues to evolve, Mayo Clinic is committed to fostering relationships and collaborations that help advance innovation beyond institutional boundaries. Earlier access to expertise and strategic guidance can help innovators navigate key decisions and identify the most effective path forward.
"The ultimate measure of innovation is whether it makes a difference in people's lives," says Peter Noseworthy, M.D., medical director for Business Development. "Strengthening the connection between innovation and commercialization helps promising discoveries gain traction beyond Mayo Clinic and creates more opportunity for impact."
The exchange will continue to play an important role in identifying opportunities, encouraging collaboration and helping innovators transform promising ideas into meaningful advances.
At its core, the effort reflects Mayo Clinic's belief that meaningful progress happens when people with diverse expertise come together to solve important challenges.
###
About the Berg Innovation Exchange
Supported by philanthropic funding, the Berg Innovation Exchange operates with impartiality, ensuring equal opportunities for all innovators and stakeholders, with an emphasis on addressing healthcare needs over individual or institutional interests.
About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news.
Media contact:
- Tom Millikin, Mayo Clinic Communications, newsbureau@mayo.edu
Related Articles